Prevalence and correlates of herpes simplex virus type 2 infection: Evaluation of behavioural risk factors

International Journal of Epidemiology

Volumn 27, Issue 1, 1998, Pages 127-134

  Van De Laar, M J W ^a   Termorshuizen, F ^a   Slomka, M J ^b   Van Doornum, G J J ^c   Ossewaarde, J M ^a   Brown, D W G ^b   Coutinho, R A ^c   Van Den Hoek, J A R ^c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^c MUNICIPAL HEALTH SERVICE   (Netherlands)

Author keywords

Epidemiology; Herpes genitalis; Risk factors; Seroprevalence; Sexual behaviour; Sexually transmitted diseases

Indexed keywords

MONOCLONAL ANTIBODY; VIRUS ANTIBODY;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL HERPES; GONORRHEA; HERPES SIMPLEX VIRUS 2; HOMOSEXUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE;

ADULT; AGE DISTRIBUTION; ANTIBODIES, VIRAL; CROSS-SECTIONAL STUDIES; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; RISK FACTORS; RISK-TAKING; SEROLOGIC TESTS; SEX DISTRIBUTION; SEXUAL BEHAVIOR;

HERPES; HUMAN HERPESVIRUS 2;

EID: 0031936631     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/27.1.127     Document Type: Article

References (21)

1. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989;321: 7-12.
2. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990;69:19-36.
3. Siegel D, Golden E, Washington E et al. Prevalence and correlates of herpes simplex infections. The population-based AIDS in multi-ethnic neighborhoods study. JAMA 1992;268:1702-08.
4. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 1994; 1325-29.
5. Slomka MJ. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus. CDR Review 1996;6:R41-R45.
6. Forsgren M, Skoog E, Jeansson S, Olofsson S, Giesecke J. Prevalence of antibodies to herpes simplex virus in pregnant women in Stock-holm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS 1994;5:113-16.
7. Johnson RE, Lee F, Hadgu A et al. US genital herpes trends during the first decade of AIDS: prevalences increased in young whites and elevated in blacks. Proceedings Xth meeting of ISSTDR, Helsinki 1993. Sex Transm Dis 1994;21(Suppl.):S109.
8. Persson K, Mansson A, Jonsson E, Nordenfelt E. Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scan J Infect Dis 1995;27:195-99.
9. Koutsky LA, Ashley RL, Holmes KK et al. The frequency of unrecognized type 2 herpes simplex virus infection among women; implications for the control of genital herpes. Sex Transm Dis 1990;17:90-94.
10. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116:197-202.
11. Koutsky LA, Stevens CA, Holmes KK et al. Underdiagnosis of genital herpes by current clinical and viral isolation procedures. N Engl J Med 1992;326:1533-39.
12. Corey L. The current trend in genital herpes. Progress in prevention. Sex Transm Dis 1994;21:S38-44.
13. Ashley RL. Laboratory techniques in the diagnosis of herpes simplex infection. Genitourin Med 1993;69:174-83.
14. Becker TM, Lee F, Daling JR, Nahmias AJ. Seroprevalence of and risk factors for antibodies to herpes simplex viruses, hepatitis B, and hepatitis C among southwestern and non-hispanic white women. Sex Transm Dis 1996;23:138-44.
15. Duynhoven YTHP van, Laar MJW van de, Fennema JSA, Doornum GJJ, Hoek JAR van den. Development and evaluation of screening strategies for Chlamydia trachomatis infections in an STD clinic. Genitourin Med 1995;71:75-81.
16. Laar MJW van de, Lan J, Duynhoven YTHP van et al. Differences in clinical manifestations of genital chlamydial infections related to serovars. Genitourin Med 1996;72:261-65.
17. Slomka MJ, Ashley RL, Cowan FM, Cross A, Brown DWG. Monoclonal antibody blocking tests for the detection of HSV-1 and HSV-2-specific humoral responses: comparison with Western blot assay. J Virol Methods 1995;55:27-35.
18. Ho DWT, Field PR, Irving WL, Pakham DR, Cunningham AL. Detection of immunoglobulin M antibodies to glycoprotein G-2 by Western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J Clin Microbiol 1993;31:3157-64.
19. Langenberg A, Benedeiti J, Ashley R, Winter C, Corey L. Development of clinically recognizable genital lesions among women previously identified as having 'asymptomatic' HSV-2 infection. Ann Intern Med 1989;110:882-87.
20. Mertz GJ, Coombs RW, Ashley R et al. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis 1988;157:1169-77.
21. Laar MJW van de, Pickering J, Hoek JAR van den, Griensven GJP, Coutinho RA, Water HPA van de. Declining gonorrhoea trends in The Netherlands, 1976-1988. Evidence for the AIDS epidemic. Genitourin Med 1990;66:148-55.